45.28
price up icon7.76%   3.26
after-market Dopo l'orario di chiusura: 45.28
loading
Precedente Chiudi:
$42.02
Aprire:
$42.07
Volume 24 ore:
1.07M
Relative Volume:
1.09
Capitalizzazione di mercato:
$3.71B
Reddito:
-
Utile/perdita netta:
$-153.72M
Rapporto P/E:
-80.86
EPS:
-0.56
Flusso di cassa netto:
$-103.81M
1 W Prestazione:
+6.09%
1M Prestazione:
+16.67%
6M Prestazione:
+201.87%
1 anno Prestazione:
+157.86%
Intervallo 1D:
Value
$42.07
$45.98
Intervallo di 1 settimana:
Value
$39.67
$45.98
Portata 52W:
Value
$11.39
$45.98

Verona Pharma Plc Adr Stock (VRNA) Company Profile

Name
Nome
Verona Pharma Plc Adr
Name
Telefono
011-44-0-2032834200
Name
Indirizzo
3 MORE LONDON RIVERSIDE, LONDON
Name
Dipendente
79
Name
Cinguettio
@VeronaPharma
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
VRNA's Discussions on Twitter

Confronta VRNA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
VRNA
Verona Pharma Plc Adr
45.28 3.71B 0 -153.72M -103.81M -2.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
405.27 104.37B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
715.13 78.59B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
628.32 37.57B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
242.26 31.25B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.51 27.21B 3.30B -501.07M 1.03B -2.1146

Verona Pharma Plc Adr Stock (VRNA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-10-03 Iniziato Wells Fargo Overweight
2023-05-22 Ripresa Jefferies Buy
2022-09-19 Ripresa Wedbush Outperform
2022-08-26 Iniziato Piper Sandler Overweight
2021-09-13 Iniziato H.C. Wainwright Buy
2020-08-25 Iniziato Jefferies Buy
2020-08-10 Iniziato Canaccord Genuity Buy
2019-04-18 Iniziato BTIG Research Buy
Mostra tutto

Verona Pharma Plc Adr Borsa (VRNA) Ultime notizie

pulisher
Dec 07, 2024

Verona Pharma CFO Mark Hahn sells shares worth $4.4 million - Investing.com India

Dec 07, 2024
pulisher
Dec 06, 2024

Verona Pharma CEO David Zaccardelli sells shares worth $4.36 million - Investing.com

Dec 06, 2024
pulisher
Dec 02, 2024

Verona Pharma's CFO Mark Hahn sells shares worth $566,821 - Investing.com India

Dec 02, 2024
pulisher
Dec 02, 2024

Verona Pharma's CFO Mark Hahn sells shares worth $566,821 By Investing.com - Investing.com South Africa

Dec 02, 2024
pulisher
Dec 02, 2024

Verona Pharma CEO David Zaccardelli sells shares worth $627,233 - Investing.com

Dec 02, 2024
pulisher
Nov 27, 2024

Verona Pharma CFO sells shares totaling $12,000 - Investing.com India

Nov 27, 2024
pulisher
Nov 27, 2024

Verona Pharma's chief medical officer sells $1.18 million in shares - Investing.com India

Nov 27, 2024
pulisher
Nov 26, 2024

Verona Pharma CEO David Zaccardelli sells shares worth $8,000 - Investing.com

Nov 26, 2024
pulisher
Nov 18, 2024

Verona Pharma director David Ebsworth buys $88,800 in shares - Investing.com India

Nov 18, 2024
pulisher
Nov 07, 2024

Verona Pharma director Christina Ackermann acquires $198,385 in shares - Investing.com

Nov 07, 2024
pulisher
Nov 05, 2024

Verona Pharma CFO Mark Hahn sells shares worth $568,386 - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

Verona Pharma CEO David Zaccardelli sells $618,657 in shares - Investing.com

Nov 05, 2024
pulisher
Nov 04, 2024

Earnings call: Verona Pharma reports Q3 results, optimistic on Ohtuvayre By Investing.com - Investing.com Nigeria

Nov 04, 2024
pulisher
Nov 04, 2024

Earnings call: Verona Pharma reports Q3 results, optimistic on Ohtuvayre - Investing.com India

Nov 04, 2024
pulisher
Nov 04, 2024

Exxon Mobil, Constellation Lead Afternoon Market Cap Stock Movers on Monday - Investing.com Nigeria

Nov 04, 2024
pulisher
Nov 04, 2024

Exxon Mobil, Constellation Lead Afternoon Market Cap Stock Movers on Monday By Investing.com - Investing.com South Africa

Nov 04, 2024
pulisher
Nov 04, 2024

Verona Pharma ADR earnings matched, revenue topped estimates By Investing.com - Investing.com UK

Nov 04, 2024
pulisher
Nov 04, 2024

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire Inc.

Nov 04, 2024
pulisher
Oct 25, 2024

Verona Pharma CFO Mark Hahn sells shares worth $632,760 - Investing.com India

Oct 25, 2024
pulisher
Oct 25, 2024

Verona Pharma CEO David Zaccardelli sells shares worth $633,895 - Investing.com India

Oct 25, 2024
pulisher
Oct 25, 2024

Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma - Barchart

Oct 25, 2024
pulisher
Oct 24, 2024

5 Biotech Stocks Likely To Outperform As Industry Prospects Look Bright - Barchart

Oct 24, 2024
pulisher
Oct 22, 2024

Verona Pharma CEO David Zaccardelli sells $2.25 million in shares - Investing.com India

Oct 22, 2024
pulisher
Oct 22, 2024

Verona Pharma CEO David Zaccardelli sells $2.25 million in shares By Investing.com - Investing.com South Africa

Oct 22, 2024
pulisher
Oct 22, 2024

Verona Pharma CFO Mark Hahn sells shares worth $2.3 million By Investing.com - Investing.com South Africa

Oct 22, 2024
pulisher
Oct 22, 2024

Verona Pharma CFO Mark Hahn sells shares worth $2.3 million - Investing.com India

Oct 22, 2024
pulisher
Oct 21, 2024

Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update - Yahoo Finance

Oct 21, 2024
pulisher
Oct 16, 2024

Market Insights: Verona Pharma Plc ADR (VRNA)’s Notable Drop of -0.55, Closing at 34.07 - The Dwinnex

Oct 16, 2024
pulisher
Oct 15, 2024

Verona Pharma Plc ADR [VRNA] Insider Activity: An Update for Investors - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Phathom Pharmaceuticals Inc [PHAT] Investment Appeal on the Rise - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Verona Pharma Plc ADR (VRNA) stock: A year of ups and downs - US Post News

Oct 15, 2024
pulisher
Oct 11, 2024

VRNA Shares Experience Decline in Value - Knox Daily

Oct 11, 2024
pulisher
Oct 09, 2024

Financial Metrics Exploration: Understanding Verona Pharma Plc ADR (VRNA) Through Ratios - The Dwinnex

Oct 09, 2024
pulisher
Oct 09, 2024

A stock that deserves closer examination: Verona Pharma Plc ADR (VRNA) - US Post News

Oct 09, 2024
pulisher
Oct 09, 2024

Verona Pharma (VRNA) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance

Oct 09, 2024
pulisher
Oct 08, 2024

Wells Fargo gives an Overweight recommendation for Verona Pharma Plc ADR (VRNA) - Knox Daily

Oct 08, 2024
pulisher
Oct 08, 2024

Verona Pharma Plc ADR’s (NASDAQ: VRNA) Stock Forecast: Increase To $38 In A Year - Stocks Register

Oct 08, 2024
pulisher
Oct 07, 2024

Prepare Yourself for Liftoff: Verona Pharma Plc ADR (VRNA) - SETE News

Oct 07, 2024
pulisher
Oct 04, 2024

Verona Pharma Plc ADR [VRNA] stock for 2,254,320 USD was sold by ZACCARDELLI DAVID - Knox Daily

Oct 04, 2024
pulisher
Oct 04, 2024

Harrow (HROW) Surges 8.4%: Is This an Indication of Further Gains? - Yahoo Finance

Oct 04, 2024
pulisher
Oct 04, 2024

Cactus Inc [WHD] Records 50-Day SMA of $59.34 - Knox Daily

Oct 04, 2024
pulisher
Oct 03, 2024

Verona Pharma stock soars to all-time high of $30.76 By Investing.com - Investing.com South Africa

Oct 03, 2024
pulisher
Oct 03, 2024

Piper Sandler maintains Overweight rating on Verona Pharma shares By Investing.com - Investing.com South Africa

Oct 03, 2024
pulisher
Oct 03, 2024

Sea Limited Sponsored ADR (SE) Stock Moves -0.17%: What You Should Know - Yahoo Finance

Oct 03, 2024
pulisher
Oct 03, 2024

Verona Pharma stock soars to all-time high of $30.76 - Investing.com

Oct 03, 2024
pulisher
Oct 03, 2024

VRNA’s Stock Market Adventure: 58.43% YTD Growth Amidst Volatility - The InvestChronicle

Oct 03, 2024
pulisher
Oct 03, 2024

Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Moves 6.2% Higher: Will This Strength Last? - Yahoo Finance

Oct 03, 2024
pulisher
Oct 03, 2024

Tesla and Nvidia Lead Afternoon Market Cap Stock Movers on Thursday - Investing.com

Oct 03, 2024
pulisher
Oct 02, 2024

MINISO Group Holding Limited Unsponsored ADR (MNSO) Outperforms Broader Market: What You Need to Know - Yahoo Finance

Oct 02, 2024
pulisher
Oct 02, 2024

Verona Pharma Plc ADR (VRNA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News

Oct 02, 2024
pulisher
Oct 01, 2024

Investing in Verona Pharma Plc ADR (VRNA) might be a great opportunity, but the stock is a bit overvalued - US Post News

Oct 01, 2024

Verona Pharma Plc Adr Azioni (VRNA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$69.84
price up icon 1.45%
$18.67
price up icon 4.48%
$39.59
price up icon 0.51%
$363.65
price up icon 1.13%
$177.70
price up icon 0.68%
$113.51
price up icon 0.38%
Capitalizzazione:     |  Volume (24 ore):